Yumei Niu

Yumei Niu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LRLiping Ren
Liping Ren
SPShuang Pan
Shuang Pan
HLHaiqing Li
Haiqing Li
YLYanping Li
Yanping Li
LHLina He
Lina He
YNYumei Niu
Yumei Niu
Graphene oxide (GO) has attracted considerable attention for biomedical applications such as drug delivery because of its two-dimensional structure, which provides a large surface area on both sides of the nanosheet. Here, a new method for titanium (Ti) surface modification involving a GO coating and aspirin (A) loading (A/Ti-GO) was developed, and the bioactive effects on mouse osteoblastic MC3T3-E1 cells were preliminarily studied. The X-ray photoelectron spectrometry indicated new C-O-N, C-Si-O-C, and C-N=C bond formation upon GO coating. Remarkably, the torsion test results showed stable bonding between the GO coating and Ti under a torsional shear force found in clinical settings, in that, there was no tearing or falling off of GO coating from the sample surface. More importantly, through π-π stacking interactions, the release of aspirin loaded on the surface of Ti-GO could sustain for 3 days. Furthermore, the A/Ti-GO surface displayed a significantly higher proliferation rate and differentiation of MC3T3-E1 cells into osteoblasts, which was confirmed by a water-soluble tetrazolium salt-8 (WST-8) assay and alkaline phosphatase activity test. Consequently, Ti surface modification involving GO coating and aspirin loading might be a useful contribution to improve the success rate of Ti implants in patients, especially in bone conditions.

8 December 2016 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
LSLeilei Shi
Leilei Shi
YHYi Hu
Yi Hu
Ang LinAng Lin
Ang Lin
CMChuan Ma
Chuan Ma
CZChuan Zhang
Chuan Zhang
XZXinyuan Zhu
Xinyuan Zhu

1 November 2019 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
GTGulnara Tuguzbaeva
Gulnara Tuguzbaeva
EYEr Yue
Er Yue
XCXi Chen
Xi Chen
LHLina He
Lina He
XLXinlei Li
Xinlei Li
BYBaofeng Yang
Baofeng Yang
Collectively migrating tumor cells have been recently implicated in enhanced metastasis of epithelial malignancies. In oral squamous cell carcinoma (OSCC), αv integrin is a crucial mediator of multicellular clustering and collective movement in vitro; however, its contribution to metastatic spread remains to be addressed. According to the emerging therapeutic concept, dissociation of tumor clusters into single cells could significantly suppress metastasis-seeding ability of carcinomas. This study aimed to investigate the anti-OSCC potential of novel endostatin-derived polypeptide PEP06 as a cluster-dissociating therapeutic agent in vitro. Firstly, we found marked enrichment of αv integrin in collectively invading multicellular clusters in human OSCCs. Our study revealed that metastatic progression of OSCC was associated with augmented immunostaining of αv integrin in cancerous lesions. Following PEP06 treatment, cell clustering on fibronectin, migration, multicellular aggregation, anchorage-independent survival and colony formation of OSCC were significantly inhibited. Moreover, PEP06 suppressed αv integrin/FAK/Src signaling in OSCC cells. PEP06-induced loss of active Src and E-cadherin from cell-cell contacts contributed to diminished collective migration of OSCC in vitro. Overall, these results suggest that PEP06 polypeptide 30 inhibiting αv integrin/FAK/Src signaling and disrupting E-cadherin-based intercellular junctions possesses anti-metastatic potential in OSCC by acting as a cluster-dissociating therapeutic agent.

18 July 2017 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
XLXiao Li
Xiao Li
LLLei Li
Lei Li
YHYu Huang
Yu Huang
BLBing Liu
Bing Liu
HCHuirong Chi
Huirong Chi
XZXinyuan Zhu
Xinyuan Zhu
MutT homolog 1 (MTH1) is an essential sanitizer of the free nucleotide pool that prevents lethal DNA damage in cancer cells, which has been validated as an anticancer target in recent years. Small molecule TH287 potently and selectively inhibits the MTH1 protein in cells. Here, we developed an effective chemotherapeutic system for oral squamous cell carcinoma (OSCC) based on polymeric nanoparticles that achieve co-delivery of anticancer drug sodium arsenite (NaAsO2) and MTH1 inhibitor TH287. Cationic hyperbranched poly(amine-ester) (HPAE), an amphiphilic and pH-sensitive polymer with a highly branched structure, self-assembled into nanoparticles in aqueous solution. Both NaAsO2 and TH287 could be loaded into HPAE nanoparticles with the help of electrostatic attraction and hydrophobic interaction. The release of NaAsO2 and TH287 from HPAE(NaAsO2 + TH287) nanoparticles was pH-dependent. In vitro evaluation demonstrated that the HPAE(NaAsO2 + TH287) nanoparticles rapidly entered cancer cells and released NaAsO2 and TH287 in response to acidic intracellular environments. In comparison with NaAsO2, TH287, HPAE(NaAsO2) nanoparticles, HPAE(TH287) nanoparticles, and the physical mixture of HPAE(NaAsO2) nanoparticles and TH287, the HPAE(NaAsO2 + TH287) nanoparticles exhibited more effective inhibition of tumor cell proliferation, illustrating the synergistic effect of NaAsO2 and TH287. The experimental results show that TH287 is likely to inhibit MTH1 in tumor cells, rendering them more sensitive to NaAsO2.

10 March 2015 in International Endodontic Journal
Verified
Journal Article
Closed access
PDF file
LHL. He
L. He
SPS. Pan
S. Pan
YLY. Li
Y. Li
LZL. Zhang
L. Zhang
WZW. Zhang
W. Zhang
YNYumei Niu
Yumei Niu

1 March 2017 in Archives of Oral Biology
Verified
Journal Article
Closed access
LSLei Shi
Lei Shi
SFShanqi Fu
Shanqi Fu
SFSidra Fahim
Sidra Fahim
SPShuang Pan
Shuang Pan
HLHe Lina
He Lina
YNYumei Niu
Yumei Niu